Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli

NCT02142751 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

161

Enrollment

OTHER

Sponsor class

Conditions

Infection Due to ESBL Escherichia Coli

Interventions

DRUG: Fosfomycin sodium intravenous
DRUG: Meropenem intravenous
DRUG: Ceftriaxone intravenous

Sponsor

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Collaborators

[object Object]